Clevers, Hans
Enlarge text Shrink text
Information for Authority record
Name (Latin)
Clevers, Hans
Other forms of name
Clevers, Johannes Carolus Hans
Date of birth
1957-03-27
Field of activity
Molecular genetics
Associate group
Rijksuniversiteit te Utrecht
Gender
male
Fuller form of name
Johannes Carolus Hans
Biographical or Historical Data
Clevers obtained his M.D. in 1984 and his Ph.D. in 1985 at Utrecht University and was a professor in immunology there between 1991 and 2002. Since then, he is Professor in Molecular Genetics at the UMC Utrecht and University Utrecht. He received the Spinoza Prize in 2001 and became director of the Hubrecht Institute in 2002. He was elected as the president of the Royal Netherlands Academy of Arts and Sciences (KNAW) to succeed Robbert Dijkgraaf from 2012-2015.[3] Clevers has his own research group at the Hubrecht Institute and is director Research of the Princess Maxima Center for pediatric oncology since 1 June 2015. In 2013 he was awarded the $3 million Breakthrough Prize in Life Sciences for his work [4]. In 2014 he became one of the national icons of the Netherlands.
Sources of Information
- Stem cells: scientific facts and fiction, 2014t.p. (Hans Clevers)
- D.O.B (27 March 1957) fuller form of personal name (Johannes Carolus (Hans) ( (Wikipedia, viewed 26 Nov. 2018) )
1 / 2
Wikipedia description:
Johannes (Hans) Carolus Clevers (born 27 March 1957) is a Dutch molecular geneticist, cell biologist and stem cell researcher. He became the Head of Pharma, Research and Early Development, and a member of the Corporate Executive Committee, of the Swiss healthcare company Roche in 2022. Previously, he headed a research group at the Hubrecht Institute for Developmental Biology and Stem Cell Research and at the Princess Máxima Center; he remained as an advisor and guest scientist or visiting researcher to both groups. He is also a Professor in Molecular Genetics at Utrecht University.
Read more on Wikipedia >